Cortex (Cor) [formerly CORX] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX]

COR 359.29

+2.1%

Jan 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cage Rattler who wrote (604)	10/20/1998 8:33:00 PM
From: DavidCG	Read Replies (1) of 1255

Up to date on what? Phase I/IIa testing on humans measures the safety to humans. The testing on rats was complete and turned out great for CX516. Any further rat testing done right now is probably on CX691 compound (a completely new drug). What did you expect NBC to say.... "Well so far, it works excellent in rats...and by the way, on a small sample of human testing there were no adverse side effects and therefore is safe to administer to humans" ? What would be the point? I will agree that it was quick NBC editing and news piece. Maybe the CEO for Cortex isn't photogenic enough for the cameras -possibly why the Psychologix guy was on instead. Who knows. -DavidCG

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next